Results 191 to 200 of about 3,152,690 (357)

Cerebrovascular disorder : an advance of diagnosis and medical treatment.3.Medical treatment of cerebrovascular disorder.7.Countermeasure for sequela of cerebrovascular disorder patient.Problems from the viewpoint of functional prognosis of our cases.

, 1991
澤田 徹
openalex   +2 more sources

How do I Know That the Jerks I See Are Tics?

Movement Disorders Clinical Practice, EarlyView.
Tics are prevalent hyperkinesias that are most often encountered in the context of a primary tic disorder, as in Tourette syndrome. Although their recognition is typically straightforward, they often share some phenomenological features with other jerky hyperkinesias and may be mislabeled as such.
Talyta Grippe, Anthony Lang, Christos Ganos   +2 more
wiley   +1 more source

Cerebrovascular disorder : an advance of diagnosis and medical treatment.3.Medical treatment of cerebrovascular disorder.1.An approach of medical treatment of acute phase cerebrovascular.

, 1991
大友 英一
openalex   +2 more sources

Sleep-Disordered Breathing and Cardio- and Cerebrovascular Diseases: 2003 Update of Clinical Significance and Future Perspectives. Schlafbezogene Atmungsstorungen und kardio- und zerebrovaskulare Erkrankungen: Update 2003 der klinischen Bedeutung und zukunftiger Entwicklungen [PDF]

, 2003
Hans‐Werner Duchna, Ludger Grote, Stefan Andreas, Richard Schulz, Thomas Wessendorf, Heinrich F. Becker, P. Clarenbach, Ingo Fietze, Holger Hein, Ulrich Koehler, Andreas Nachtmann, Winfried Randerath, Kurt Rasche, Karl-Heinz Rühle, Bernd Sanner, H. Schäfer, Richard Staats, Volker Töpfer   +17 more
openalex   +1 more source

Speech Differences between Multiple System Atrophy and Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Delineation of Parkinson's disease (PD) from multiple system atrophy (MSA) can be challenging in early disease stages. Speech characteristics have been studied as digital biomarkers in PD and ataxias. Currently, data on speech in MSA is limited.
Tom Hähnel, Anna Nemitz, Katja Schön, Luise Berger, Annemarie Vogel, Doreen Gruber, Nils Schnalke, Stefan Bräuer, Björn H. Falkenburger, Florin Gandor   +9 more
wiley   +1 more source

Chinese medical treatment for cerebrovascular disorder.

, 1991
Hisaya Kogure
openalex   +2 more sources

Sleep-related breathing disorders: impact on mortality of cerebrovascular disease [PDF]

, 2004
Olga Parra, Adrià Arboix, Josep M. Montserrat, Llorenç Quintó, S. Bechich, Luis García‐Eroles   +5 more
openalex   +1 more source

Long‐Term Safety and Efficacy of Repeat Treatments with DaxibotulinumtoxinA in Cervical Dystonia: Results from the ASPEN‐Open‐Label Study

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background DaxibotulinumtoxinA (DAXI), a novel botulinum neurotoxin (BoNT) formulation, was shown to be safe, effective, and long‐lasting in the treatment of cervical dystonia (CD) over one treatment cycle in the phase 3, randomized, placebo‐controlled ASPEN‐1 trial.
Peter McAllister, Atul T. Patel, Marta Banach, Aaron Ellenbogen, Jaroslaw Slawek, Sebastian Paus, Hyder A. Jinnah, Virgilio Evidente, Todd M. Gross, Rashid Kazerooni, Conor J. Gallagher, David A. Hollander   +11 more
wiley   +1 more source

Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of intracerebral haemorrhage. [PDF]

Stroke Vasc Neurol, 2020
Cao Y, Yu S, Zhang Q, Yu T, Liu Y, Sun Z, Zhao M, Wang W, Zhao JZ, Chinese Stroke Association Stroke Council Guideline.   +9 more
europepmc   +1 more source

Clinical Evaluation of Nicergoline in Cerebrovascular Dementia Disorders: Therapeutic Effects of Nicergoline Powder.

, 1991
Hiroshi Inoué, Etsuo Fukuma, Ken Watanabe, Kiyoshi Doi, Kousuke Komatsubara, Touji MATSUSHITA, Atsushi Ihara, Shuusaku KUBA, Tokuo SUGIHARA, Hisayuki Tachibana, Kenji Imaoka, Itsuyuki Koga, Y. Uchida, Junji Takasu   +13 more
openalex   +2 more sources